JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1677/jme.0.0260031

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (38)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Porter, W
Right arrow Articles by Safe, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Porter, W
Right arrow Articles by Safe, S
Journal of Molecular Endocrinology, Vol 26, Issue 1, 31-42
Copyright © 2001 by Society for Endocrinology


Articles

Transcriptional activation of heat shock protein 27 gene expression by 17beta-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists

W Porter, F Wang, R Duan, C Qin, E Castro-Rivera, K Kim, and S Safe


Heat shock protein 27 (Hsp 27) is expressed in mammary tumors and may play a role in tumor growth and response to anti-neoplastic drug therapy. 17beta-Estradiol (E2) induces Hsp 27 mRNA levels in MCF-7 human breast cancer cells, and we have investigated the comparative inhibitory mechanisms using the aryl hydrocarbon receptor (AhR) agonist, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and the direct-acting antiestrogen ICI 164,384. TCDD inhibited E2-induced Hsp 27 gene expression and analysis of the Hsp 27 gene promoter showed that the inhibitory response was associated with AhR interactions with a pentanucleotide motif at -3 to +2 in the promoter that corresponded to the core sequence of a dioxin responsive element. In contrast, ICI 164,384 induced Hsp 27 gene expression and reporter gene activity in MCF-7 cells and this represents one of the few examples of the estrogen receptor-alpha (ERalpha) agonist activity of the 'pure' antiestrogen ICI 164,384.


This article has been cited by other articles:


Home page
Circ. Res.Home page
K. Rayner, Y.-X. Chen, M. McNulty, T. Simard, X. Zhao, D. J. Wells, J. de Belleroche, and E. R. O'Brien
Extracellular Release of the Atheroprotective Heat Shock Protein 27 Is Mediated by Estrogen and Competitively Inhibits acLDL Binding to Scavenger Receptor-A
Circ. Res., July 18, 2008; 103(2): 133 - 141.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Singhal, K. Shankar, T. M. Badger, and M. J. Ronis
Estrogenic status modulates aryl hydrocarbon receptor--mediated hepatic gene expression and carcinogenicity
Carcinogenesis, February 1, 2008; 29(2): 227 - 236.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. R. Boverhof, L. D. Burgoon, K. J. Williams, and T. R. Zacharewski
Inhibition of Estrogen-Mediated Uterine Gene Expression Responses by Dioxin
Mol. Pharmacol., January 1, 2008; 73(1): 82 - 93.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. M. Jaber, T. Gao, L. Huang, S. Karmakar, and C. L. Smith
The Pure Estrogen Receptor Antagonist ICI 182,780 Promotes a Novel Interaction of Estrogen Receptor-{alpha} with the 3',5'-Cyclic Adenosine Monophosphate Response Element-Binding Protein-Binding Protein/p300 Coactivators
Mol. Endocrinol., November 1, 2006; 20(11): 2695 - 2710.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Khan, R. Barhoumi, R. Burghardt, S. Liu, K. Kim, and S. Safe
Molecular Mechanism of Inhibitory Aryl Hydrocarbon Receptor--Estrogen Receptor/Sp1 Cross Talk in Breast Cancer Cells
Mol. Endocrinol., September 1, 2006; 20(9): 2199 - 2214.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. K. Hockings, P. A. Thorne, M. Q. Kemp, S. S. Morgan, O. Selmin, and D. F. Romagnolo
The Ligand Status of the Aromatic Hydrocarbon Receptor Modulates Transcriptional Activation of BRCA-1 Promoter by Estrogen
Cancer Res., February 15, 2006; 66(4): 2224 - 2232.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. A. Lee, D. Ndisang, C. Patel, J. H. Dennis, D. J. Faulkes, C. D'Arrigo, L. Samady, S. Farooqui-Kabir, R. J. Heads, D. S. Latchman, et al.
Expression of the Brn-3b Transcription Factor Correlates with Expression of HSP-27 in Breast Cancer Biopsies and Is Required for Maximal Activation of the HSP-27 Promoter
Cancer Res., April 15, 2005; 65(8): 3072 - 3080.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
F Gadal, A Starzec, C Bozic, C Pillot-Brochet, S Malinge, V Ozanne, J Vicenzi, L Buffat, G Perret, F Iris, et al.
Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells
J. Mol. Endocrinol., February 1, 2005; 34(1): 61 - 75.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. Kim and M. R. Stallcup
Role of the Coiled-coil Coactivator (CoCoA) in Aryl Hydrocarbon Receptor-mediated Transcription
J. Biol. Chem., November 26, 2004; 279(48): 49842 - 49848.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Chen, M. Hewison, B. Hu, M. Sharma, Z. Sun, and J. S. Adams
An Hsp27-related, Dominant-negative-acting Intracellular Estradiol-binding Protein
J. Biol. Chem., July 16, 2004; 279(29): 29944 - 29951.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
B. Santiago-Josefat, S. Mulero-Navarro, S. L. Dallas, and P. M. Fernandez-Salguero
Overexpression of latent transforming growth factor-{beta} binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts
J. Cell Sci., February 22, 2004; 117(6): 849 - 859.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Khan, M. Abdelrahim, I. Samudio, and S. Safe
Estrogen Receptor/Sp1 Complexes Are Required for Induction of cad Gene Expression by 17{beta}-Estradiol in Breast Cancer Cells
Endocrinology, June 1, 2003; 144(6): 2325 - 2335.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Brunnberg, K. Pettersson, E. Rydin, J. Matthews, A. Hanberg, and I. Pongratz
The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription
PNAS, May 27, 2003; 100(11): 6517 - 6522.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. Kim, N. Thu, B. Saville, and S. Safe
Domains of Estrogen Receptor {alpha} (ER{alpha}) Required for ER{alpha}/Sp1-Mediated Activation of GC-Rich Promoters by Estrogens and Antiestrogens in Breast Cancer Cells
Mol. Endocrinol., May 1, 2003; 17(5): 804 - 817.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Wormke, M. Stoner, B. Saville, K. Walker, M. Abdelrahim, R. Burghardt, and S. Safe
The Aryl Hydrocarbon Receptor Mediates Degradation of Estrogen Receptor {alpha} through Activation of Proteasomes
Mol. Cell. Biol., March 15, 2003; 23(6): 1843 - 1855.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Endocrinology.